MEI Pharma Inc banner

MEI Pharma Inc
NASDAQ:MEIP

Watchlist Manager
MEI Pharma Inc Logo
MEI Pharma Inc
NASDAQ:MEIP
Watchlist
Price: 3.07 USD 10.43% Market Closed
Market Cap: $100.8m

Cash Flow Statement

Cash Flow Statement
MEI Pharma Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025
Operating Cash Flow
Net Income
(36)
(33)
(28)
(24)
(21)
(21)
(21)
(4)
1
3
(2)
(20)
(25)
(40)
(46)
(28)
(39)
(17)
(5)
(38)
(24)
(47)
(43)
(31)
(64)
(41)
(60)
(64)
(35)
(54)
(54)
(31)
(38)
(32)
41
20
26
18
(47)
(38)
(32)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
Other Non-Cash Items
5
4
4
3
3
3
3
3
3
2
3
3
3
13
19
(4)
2
(21)
(35)
(3)
(16)
30
27
13
31
(8)
2
4
(18)
(11)
(11)
(7)
4
4
4
4
4
16
15
13
12
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
3
0
(2)
(4)
(3)
0
14
(2)
(1)
(2)
(13)
4
2
6
(1)
11
12
8
10
(3)
(3)
51
56
72
82
17
27
17
8
17
8
(23)
(23)
(25)
(102)
(78)
(74)
(84)
(12)
(12)
(17)
Cash from Operating Activities
(27)
N/A
(28)
-3%
(27)
+3%
(25)
+8%
(21)
+15%
(18)
+15%
(3)
+81%
(3)
+15%
3
N/A
3
+11%
(12)
N/A
(13)
-9%
(21)
-61%
(21)
-3%
(28)
-29%
(20)
+27%
(25)
-25%
(29)
-17%
(31)
-4%
(44)
-43%
(43)
+2%
34
N/A
39
+15%
54
+37%
48
-10%
(32)
N/A
(31)
+4%
(43)
-41%
(44)
-3%
(49)
-10%
(56)
-14%
(62)
-10%
(57)
+8%
(52)
+7%
(56)
-7%
(53)
+6%
(44)
+17%
(50)
-15%
(43)
+14%
(36)
+17%
(36)
-1%
Investing Cash Flow
Capital Expenditures
(0)
(0)
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
0
0
(0)
(0)
(0)
0
(0)
(1)
(1)
(2)
(2)
(1)
(1)
(0)
(0)
(0)
(0)
(1)
0
0
(0)
(0)
(0)
(0)
(0)
0
0
0
Other Items
(15)
(10)
(15)
15
15
10
(5)
0
(10)
(10)
5
5
15
(44)
(45)
(50)
(45)
25
25
(11)
(10)
(105)
(105)
(75)
(70)
25
35
(3)
(3)
7
6
60
55
54
45
59
49
49
59
55
55
Cash from Investing Activities
(15)
N/A
(10)
+33%
(15)
-50%
15
N/A
15
+0%
10
-33%
(5)
N/A
0
N/A
(10)
N/A
(10)
-1%
5
N/A
5
-1%
15
+204%
(44)
N/A
(45)
-1%
(50)
-12%
(45)
+9%
24
N/A
25
+1%
(11)
N/A
(11)
-6%
(106)
-841%
(107)
0%
(77)
+28%
(70)
+8%
25
N/A
35
+43%
(3)
N/A
(3)
-8%
7
N/A
6
-18%
60
+956%
54
-9%
54
-1%
45
-16%
59
+31%
49
-17%
49
+0%
59
+20%
55
-7%
55
0%
Financing Cash Flow
Net Issuance of Common Stock
43
43
0
0
0
0
4
4
4
4
0
0
0
70
72
71
72
2
1
49
49
70
73
24
24
3
0
53
53
53
0
0
0
0
0
0
0
0
0
0
0
Cash Paid for Dividends
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(12)
(12)
(12)
0
0
0
Other
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
5
5
5
5
0
(0)
0
0
(0)
(4)
(4)
(4)
(4)
(0)
(0)
(0)
0
0
0
(0)
0
0
0
Cash from Financing Activities
43
N/A
43
+0%
0
N/A
0
N/A
0
N/A
0
N/A
4
N/A
4
N/A
4
N/A
4
N/A
0
-100%
0
+850%
0
N/A
70
+36 995%
71
+1%
71
0%
71
+0%
1
-98%
6
+336%
54
+799%
54
0%
75
+38%
73
-3%
24
-67%
24
+1%
3
-86%
0
-99%
49
+244 200%
49
+0%
49
0%
49
+0%
0
-99%
(0)
N/A
(0)
-100%
0
N/A
(12)
N/A
(12)
N/A
(12)
-2%
0
N/A
(0)
N/A
(0)
N/A
Change in Cash
Net Change in Cash
1
N/A
5
+533%
1
-83%
(10)
N/A
(6)
+38%
(8)
-28%
(4)
+48%
1
N/A
(3)
N/A
(2)
+11%
(7)
-187%
(8)
-13%
(5)
+29%
5
N/A
(1)
N/A
1
N/A
1
-13%
(4)
N/A
(0)
+97%
(0)
+17%
0
N/A
3
+9 067%
5
+81%
1
-75%
2
+85%
(4)
N/A
5
N/A
3
-43%
1
-48%
7
+421%
(1)
N/A
(2)
-68%
(2)
-42%
1
N/A
(11)
N/A
(6)
+49%
(6)
-12%
(13)
-105%
4
N/A
19
+419%
18
-2%
Free Cash Flow
Free Cash Flow
(27)
N/A
(28)
-3%
(27)
+4%
(25)
+8%
(21)
+15%
(18)
+15%
(3)
+81%
(3)
+15%
3
N/A
3
+10%
(12)
N/A
(13)
-8%
(21)
-61%
(21)
-3%
(28)
-29%
(20)
+27%
(25)
-25%
(30)
-17%
(31)
-4%
(44)
-43%
(44)
+1%
33
N/A
38
+13%
52
+38%
48
-9%
(33)
N/A
(31)
+6%
(43)
-41%
(45)
-3%
(49)
-10%
(56)
-14%
(62)
-9%
(57)
+8%
(53)
+7%
(56)
-7%
(53)
+6%
(44)
+17%
(50)
-15%
(43)
+14%
(36)
+17%
(36)
-1%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett